A TRIGLYCERIDE ANALYSIS COMPOSITION AND A METHOD FOR TRIGLYCERIDE DETERMINATION

Abstract: The invention relates to a composition for use in mak­ ing a triglyceride determination which consists essentially of at least one bacterial lipase derived from a bacteria source in the group consisting of Pseudomonas species and Chromobacterium species; and a glycerol detection reagent. The invention further relates to a method for tri­ glyceride determination.

Description: A A Triglyceride Analysis Composition and a Method for Triglyceride Determination The invention relates to a composition and method for a triglyceride determination and particularly to the triglyceride determination of animal serum, especially, human serum. In many fields it is important to determine triglyceride concentration of a substance. This is particularly important in clinical biochemistry. The determination of triglyceride concentration in human serum is an important part of routine lipid analysis in clinical chemistry. There are numerous prior art compositions and methods. The drawbacks of the prior art are primarily due to the time needed to carry out the methods, the accuracy and reliability of the determination, and the linearity of the determination for high levels of triglycerides concentration. The instant invention overcomes these draw backs by providing a fast and accurate endpoint reaction which does not require a pre-incubation step. By "endpoint reaction" it is meant that all of the trigly cerides in a human serum can be converted to a detectable product. Typically, the determination can be made in less than 4 minutes from a single formulation or mixture of components. Furthermore, the invention is effective for a determination of serum triglycerides in a concen tration of up to at least 1000 mg per dL of serum. Prior art methods require such high levels to be diluted to lower levels before an accurate measurement can be made. As used herein, one lipase unit is defined as the amount which will release one micromole of fatty acid per minute from emulsified olive oil at 220C and pH 7.5 in a reaction mixture as follows: 0.4 M sodium chloride 6 millimolar magnesium sulphate.7H2Q 5 millimolar calcium chloride 2H20 0.67 mg bovine serum albumen per milliliter of the reaction mixture 137 mg olive oil in suspension per milliliter of the reaction mixture In its broadest scope, the invention features a triglyceride analysis composition for use in the triglyceride determination of serum, consisting essentially of at least one bacterial lipase derived from a bacteria source in the group consisting of Pseudomonas species and Chromobacterium species and in the amount of at least about 700 lipase units per mg triglycerides in the serum, and a glycerol detection reagent. One preferred embodiment of the invention is a triglyceride analysis composition comprising a bac terial lipase derived from Pseudomonas fluorescens, and a glycerol detection reagent. Another preferred embodiment of the invention features a triglyceride analysis composition consisting essentially of a bacterial lipase derived from Chromo bacterium viscosum, and a glycerol detection reagent. Yet another preferred embodiment features a triglyceride analysis composition consisting essentially of bacterial lipases derived from Pseudomonas fluorescens and Chromobacterium viscosum, and a glycerol detection reagent. Other Pseudomonas species include Pseudomonas fragi, and Pseudomonas aeruginonsa. Other Chromobac- terum species include Chromobacterium violac-eum As used herein, "serum" refers to animal serum and particularly to human serum. In its broadest scope, the invention also features the method of triglyceride determination of a specimen, comprising the steps of combining the specimen with at least one bacterial lipase derived from a bac terial source in the group consisting of Pseudomonas species and Chromobacterium species and in the amount of at least about 700 lipase units per mg triglycerides in the specimen1 and measuring the glycerol content obtained. Preferably, the lipase is combined with a glycerol detection reagent to define a composition for a so-called one-step triglyceride analysis. The instant invention utilizes the surprising discovery that a bacterial lipase derived from a bacterial source in the group consisting of Pseudomonas species and Chromobacterium species are effective for the complete and rapid hydrolysis of triglycerides in serum. Preferably, the use of at least about 700 lipase units per mg triglycerides of serum is used. The number of lipase units used in a reaction mixture should be selected to hydrolyze the maximum amount of triglycerides present. For human serum, more than 1000 mg per dL of serum is unusual so that this can be used as a target level. Then, the results of the triglyceride determination would be reliable in that a person determined to have an above average triglycerides concentration would be correctly informed. It is understood that the invention need not be limited to animal serum in view of known technology and the generalization is understood without being specifically pOinted out. As used herein, "reaction mixture" is a combination of the instant composition and the serum. The serum could be undiluted or diluted animal serum. Nevertheless, the serum will still be identified as "serum" or "animal serum" or "human serum' without specific reference to dilution. In carrying out the invention, it is understood that the handling of the instant lipases is con -sistent with prior art practices as to storage, and environmental conditions for the reaction with the serum. In addition, glycerol detection reagents are well known in the art, particularly for measurements using an automated analyzer. Illustrative, non-limiting examples of the invention are set out below. Numerous other examples can be readily evolved in the light of the guiding principles and teachings contained herein. Example 1 Tests were carried out to demonstrate the effectiveness of the lipases of the invention to hydrolyze completely within 4 minutes the triglycerides in human serum having a concentration of about 1000 mg triglycerides per dL of serum. This is an unusually high concentration for human serum. The serum triglycerides were evaluated by conventional alkaline saponification to be 1045 + 65 mg triglycerides per dia of serum. Various relative concentrations of Pseudonomas fluorescens and Chromobacterium viscosum were used as shown in Table 1. Table 1 Lipase Lipase Units per int of Reaction Mixture Sample Pseudomonas. Chromobacterium No. fluorescens viscosum 1 100 0 2 95 5 3 90 10 4 50 50 5 10 90 6 0 100 Each reaction mixture contained the following components: -155.6 l of a lipase sample (containing 540 lipase units per mL in accordance with the relative amounts shown in Table 1), -544.4 l of a 58.5 mM phosphate buffer having a pH of 7.6, -2.1 l of a 1.2M MgSO4 0 solution These components were placed in respective tubes and were equilibrated at 300C. Then, 10 jil of serum was added to each tube to complete each reaction mixture and make a total volume of 810 jil. After 4 minutes, each tube was subjected to rapid heating to about 1000C to quench any reaction which might be taking place. The tubes were cooled to room temperature and 61.5 1 of a 1.2M MgS04-7H20 was added to each tube in order to precipate any free fatty acids to obtain a clear solution. A clear solution is desirable for measurements made with a spectrophotometer. Thereafter, a conventional glycerol detection reagent was used in accordance with conventional methods to measure the glycerol content from which the trigly cerides concentration can be computed. The lipase samples determined the trigly cerides concentration of the serum as shown in Table 2. Each measured value is a mean of 3 values + standard deviation. Table 2 Lipase Sample Lipase Ratio Value of Number Pseudomonas/Chromobacterium mg/dL of Serum 1 10073 Pseudomonas 1155 + 148 2 95:5 1155 + 44 3 90:10 903 + 103 4 50:50 1333 + 399 5 10:90 1066 + 148 6 100% Chromobacterium 1096 + 74 Statistically, the values measured using the Lipase Samples 1 to 6 are equivalent to the value obtained by the prior art alkaline saponification. This shows that the hydrolysis for each Lipase Sample 1 to 6 was an endpoint reaction as well as being faster than the prior art reactions because each reaction was completed within 4 minutes in view of the quenching step. Example 2 Example 2 was carried out to show that a triglyceride analysis composition according to the invention could obtain an accurate determination rapidly. Any one of the Lipase Samples 1 to 6 of the Example 1 would be suitable for these tests. The Lipase Sample 3 having a lipase ratio of Pseudomonas fluorescens to Chromobacterium viscosum of about 90:10 in the amount of 100 lipase units per mL of the composition. The glycerol detection reagent for the best mode was formulated as follows: a. All of the components for the reagent were preweighed prior to formulation and stored dessicated at appropriate temperatures. b. A potassium phosphate buffer was prepared and the pH of the buffer was adjusted to be about 7.5 at room temperature. c. Bovine serum albumen (crystallized, lyophilized) was added to the buffer. d. The other components were then added to the buffer as dry powders or as concentrated solutions in the following order: (i) Adenosine triphosphate (ATP) (ii) Phosphoenol pyruvate (PEP) (iii) Nicotine Adenine Dinucleotide (reduced form) (NADH) (iv) MgS04 7H20 (v) Glycerol Kinase (lyophilized powder preferred) (vi) Pyruvate Kinase (lyophilized powder preferred) (vii) Lactate Dehydrogenase (lyophilized powder preferred) (viii) Selected lipase The completed formulation was used immediately after it was prepared or stored at 40C for several hours prior to its use. The amounts of various components used in the reagent are shown in Table 3: Table 3 Quantity per mL of Triglyceride Analysis Component Composition I ATP 0.404 mg PEP (monocyclohexyl ammonium salt) 0.214 mg NADH -0.223 mg MgS04b7H20 0.764 mg glycerol kinase 2.1 IU pyruvate kinase 4.2 IU lactate dehydrogenase 4.1 1U potassium phosphate (monobasic) 1.16 mg potassium phosphate (dibasic) 10.103 mg Bovine serum albumen z 3.40 mg An automated analzer manufactured and marketed by Union Carbide Corp. under the trademark CentrifiChem 400 System (Analyzer and Pipettor) was used. The instrument settings were such that the following parameters were obtained: wavelength = 340 nm temperature = 300C initial reading (to) = 15 seconds final reading (tf) = 4 minutes 15 seconds time interval = 4 minutes serum volume = 5 P1 water added = 50 1 1 triglyceride analyzer composition = 350 1 The triglycerides concentration of each serum sample was calculated according to the formula: Triglycerides (mg/dL)=(A-A)-4 av. & & ommat; H mol. dilution x 100 X t gx factor Ao = initial absorbance (to = 15 seconds) final absorbance (4 min. 15 sec.) # N3A4D0H = 6.23 x 103 abs. units cm2mmol-l dilution factor = 80 + 1 = 81 Performance characteristics using the Cen trifichem 400 R system are shown in Table 4 were achieved: Table 4 Precision Average . Std. Coefficient No. of Value Deviation of Variance Replicates x(mg/dL) (mg/dL) (%) Within-Run Comparison Normal Control 22 46.4 1.87 4.0 Elevated Lipid 23 141 3.0 2.2 Control Between-Run Comparison Normal Control 115 49 - 3.0 Elevated Lipid 115 146 - 3.2 Control A comparison of the determination by instant invention to two different prior art methods gave the following correlation statistics: a) Triglyceride Analysis Reagent vs SKI method (ultraviolet enzymatic method of SKI Corp.) No. of Samples = 78 y = 1.10x - 11 (least squares line) r = 0.996 (correlation coefficient) b) Triglyceride Analysis Reagent vs. Dow Method (visible enzymatic method of Dow Chemical Corp.) No. of Samples = 56 y = 1.20x - 21.0 (least squares line) r = 0.974 (correlation coefficient) Esample 3 Tests were carried out to compare measured triglycerides concentration of human serum for different units of the lipase Pseudomonas fluorescens. A pooled serum was used in the procedure of the Example 2.- The lipase units were based on the triglyceride analysis composition. Table 5 shows the results: Table 5 Lipase Units Triglycerides per mL Concentration Composition mg/dL 100 248 125 248 150 259 200 260 The measured values show consistent values independent of the lipase level over a wide range of lipase units per mL of composition. Example 4 Tests were carried out to determine the linearity of response of the composition to serum tri glycerides concentration as indicated by the relationship between triglycerides concentration and absorbance units. A Centrifichem 40 system was used. To establish a reference a serum pool was diluted with 0.15 M sodium chloride 1:2 and a conventional method was used to measure triglycerides concentration. The undiluted serum pool was found to contain 1185 mg per dL of;lserum. Serum samples containing concentrations of 100, 300, 500, 700, 800, and 1000 mg triglycerides per dL of serum were prepared from aliquots of the serum pool by diluting with 0.15 M sodium chloride. Using the procedure of the Example 2, the results obtained are shown in Table 6. Table 6 Conventional Instant Method Method Concentration Concentration Ratio s ASs3çnnce Triglycerides mg/dL Triglycerides mg/dL lnst. /Conv. Units 100 106 1.06 0.102 300 316 1.05 0.296 500 530 1.06 0.493 700 751 1.07 0.697 800 860 1.08 0.797 1000 1094 1.09 1.014 The instant composition has a surprisingly linear response to the triglycerides concentration according to the relationship shown in Table 6 between concentration and observed absorbance units. Example 5 Tests were carried out to determine the reaction progress over time for the instant composition. In accordance with the Example 2, samples of human sera were prepared with the triglycerides concentrations of 80 mg per dL, 140 mg per dL, 230 mg per dL, and 350 mg per dL. Three combinations of lipases were used. The respective Pseudomonas fluores cens: Chromobacterium viscosum ratios were 90:10, 75:25, and 50:50. In each case, 100 lipase units per mL of composition were used. Using the procedure of the Example 2, it was found that each of the measurements of the human sera for each lipase combination stabilized and was completed well within 4 minutes. Tests were carried out to optimize and determine the range of the respective components of the instant composition for its use as a single component in connection with an automated system as in the Example 2. The following parameters were determined: The ratio of the enzymes glycerol kinase, pyruvate kinase, and lactic dehydrogenase was found to be critical. The ratio of pyruvate kinase to lactic dehydrogenase should be about 1:1 and the ratio of glycerol kinase to either of the other enzymes should be about 1:2. Changes in these ratios affect linearity and sensitivity. A reduction in overall concentration will eventually reduce overall reaction rate. For NADH, the initial absorbance reading at 340 nm determines the linearity. Freshly prepared composition has a theoretical absorbance value = 340 nm of 1.8, due to NADH. An absorbance value at 340 nm of 1.0 provides good linearity for triglycerides concentrations up to at least 1000.mg per dL serum. Phosphate was selected as the buffer to minimize interference from serum-containing phosphatases. High levels of the phosphate buffer can tend to inhibit the glycerol detection reagent or produce a magnesium phosphate precipitation. Low levels can be insufficient to provide buffering. Other buffers can be used satisfactorily in accordance with prior art practice. Magnesium sulphate in the range of from about 3.1 mM to about 6.0 mM has been tested. The higher levels tended to result in a precipitation in the presence of NH4+. A pH range of from about 6.9 to about 7.6 has been found acceptable within the constraint on the buffer given above. NADH stability tends to decrease for a pH below about 7. Preferably, the glycerol detect ion reagent should have a pH in the range of from about 7.5 to about 7.6. We wish it to be understood that we do not desire to be limited to the exact details described, for obvious modifications will occur to a person skilled in the art.

Claims: What IS CLAIMED IS: 1. A triglyceride analysis composition for use in the triglyceride determination'of serum, consisting essentially of at least one bacterial lipase derived from a bacteria source in the group consisting of Pseudomonas species and Chromobacterium species and in the amount of at least about 700 lipase units per mg triglycerides in the serum and a glycerol detection reagent. 2. A triglyceride analysis composition according to claim 1 comprising a bacterial lipase derived from Pseudomonas fluorescens, and a glycerol detection reagent. 3. A triclyceride analysis composition according to claim 1, consisting essentially of a bacterial lipase derived from Chromobacterium viscosum, and a glycerol detection reagent. 4. A triglyceride analysis composition according to claim 1 consisting essentially of bacterial lipases derived from Pseudomonas fluorescens and Chromobacterium viscosum, and a glycerol detection reagent. 5. A method f . triglYceriSeetermination of a specimen, comprising the steps of combining the specimen with at least one bacterial lipase derived from a bac terial lipase derived from a bacterial source in the group consisting of Pseudomonas species and Chromobacterium species and in the amount of at least about 700 lipase units per mg triglycerides in the specimen, and measuring the glycerol content obtained. 6. A method -according to claim 5 comprising the steps of combining the specimen with a bacterial lipase derived from Pseudomonas fluorescens, and measuring.the glycerol content obtained. 7. A method according to claim 5 - comprising the steps of combining the specimen with a composition consisting essentially of a bacterial lipase derived from Chromobacterium species, and a glycerol detection reagent; and measuring the glycerol content obtained.

Inventors: BATTEY, YORK C., MATTEO, MARTHA R.
Applicants: BAKER INSTRUMENTS CORPORATION
Application year: 1981
Main classification: C12Q1
IPC codes: C12N9, C12Q1